(Q79922062)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082921%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

review article

1 reference

title

Cyclins and breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082921%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

Robert L Sutherland

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082921%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Elizabeth A Musgrove

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082921%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082921%20AND%20SRC:MED&resulttype=core&format=json

Journal of Mammary Gland Biology and Neoplasia

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082921%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082921%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

95-104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082921%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15082921%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/b:jomg.0000023591.45568.77

27 December 2019

exact match

0 references

cites work

C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells

1 reference

12 December 2020

Development of mice expressing a single D-type cyclin.

1 reference

12 December 2020

The regulation of E2F by pRB-family proteins

1 reference

12 December 2020

Cyclin E, a potential prognostic marker for breast cancer

1 reference

12 December 2020

Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer

1 reference

12 December 2020

Genetic evidence for the interactions of cyclin D1 and p27(Kip1) in mice

1 reference

12 December 2020

Cyclin D1, EMS1 and 11q13 amplification in breast cancer

1 reference

12 December 2020

Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining

1 reference

12 December 2020

Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells

1 reference

12 December 2020

Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis

1 reference

12 December 2020

A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer

1 reference

12 December 2020

Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells

1 reference

12 December 2020

Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells

1 reference

12 December 2020

Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle

1 reference

12 December 2020

Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27(Kip1) association with cyclin E-Cdk2.

1 reference

12 December 2020

Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types

1 reference

12 December 2020

Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice

1 reference

12 December 2020

17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells

1 reference

12 December 2020

Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells

1 reference

12 December 2020

Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment

1 reference

12 December 2020

Cyclin D1 and prognosis in human breast cancer.

1 reference

12 December 2020

Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast.

1 reference

12 December 2020

Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice

1 reference

12 December 2020

Cyclin D1 expression and patient outcome after tamoxifen therapy in estrogen receptor positive metastatic breast cancer.

1 reference

12 December 2020

Cyclin E and survival in patients with breast cancer

1 reference

12 December 2020

New functional activities for the p21 family of CDK inhibitors

1 reference

12 December 2020

Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions

1 reference

12 December 2020

Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer

1 reference

12 December 2020

The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node

1 reference

12 December 2020

Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.

1 reference

12 December 2020

Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells

1 reference

12 December 2020

Redundant cyclin overexpression and gene amplification in breast cancer cells

1 reference

12 December 2020

Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells.

1 reference

12 December 2020

The Hallmarks of Cancer

1 reference

12 December 2020

Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays

1 reference

12 December 2020

Initiating oncogenic event determines gene-expression patterns of human breast cancer models

1 reference

12 December 2020

Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer

1 reference

12 December 2020

Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4

1 reference

12 December 2020

Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution

1 reference

12 December 2020

Linking cyclins to transcriptional control.

1 reference

12 December 2020

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

1 reference

12 December 2020

Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast

1 reference

12 December 2020

Cyclin D1 provides a link between development and oncogenesis in the retina and breast.

1 reference

12 December 2020

Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells

1 reference

12 December 2020

A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer

1 reference

12 December 2020

Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution

1 reference

12 December 2020

A low abundance pool of nascent p21WAF1/Cip1 is targeted by estrogen to activate cyclin E*Cdk2.

1 reference

12 December 2020

Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.

1 reference

12 December 2020

p27(Kip1) induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells

1 reference

12 December 2020

CDK inhibitors: positive and negative regulators of G1-phase progression

1 reference

12 December 2020

CDK-independent activation of estrogen receptor by cyclin D1

1 reference

12 December 2020

Alternative mammary oncogenic pathways are induced by D-type cyclins; MMTV-cyclin D3 transgenic mice develop squamous cell carcinoma

1 reference

12 December 2020

Prognostic value of combined analysis of cyclin D1 and estrogen receptor status in breast cancer patients

1 reference

12 December 2020

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

1 reference

12 December 2020

Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer

1 reference

12 December 2020

Differential modulation of cyclin gene expression by MYC

1 reference

12 December 2020

Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation

1 reference

12 December 2020

Expression and amplification of cyclin genes in human breast cancer

1 reference

12 December 2020

To cycle or not to cycle: a critical decision in cancer.

1 reference

12 December 2020

Cyclin D1 in breast cancer

1 reference

12 December 2020

Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint

1 reference

12 December 2020

A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence

1 reference

12 December 2020

Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells.

1 reference

12 December 2020

Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer.

1 reference

12 December 2020

Mechanisms of cyclin-dependent kinase inactivation by progestins

1 reference

12 December 2020

Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.

1 reference

12 December 2020

Rescue of Cyclin D1 Deficiency by Knockin Cyclin E

1 reference

12 December 2020

Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression

1 reference

12 December 2020

Specific protection against breast cancers by cyclin D1 ablation

1 reference

12 December 2020

Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E

1 reference

12 December 2020

Cyclin E as a coactivator of the androgen receptor

1 reference

12 December 2020

Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.

1 reference

12 December 2020

Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation

1 reference

12 December 2020

Regulation of the functional interaction between cyclin D1 and the estrogen receptor

1 reference

12 December 2020

c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry

1 reference

12 December 2020

Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer

1 reference

12 December 2020

Determination of the prognostic value of cyclin D1 overexpression in breast cancer.

1 reference

12 December 2020

Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes

1 reference

12 December 2020

Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo

1 reference

12 December 2020

The oncogenic activity of cyclin E is not confined to Cdk2 activation alone but relies on several other, distinct functions of the protein

1 reference

12 December 2020

Principles of CDK regulation

1 reference

12 December 2020

Constitutive MEK/MAPK activation leads to p27(Kip1) deregulation and antiestrogen resistance in human breast cancer cells

1 reference

12 December 2020

Functional analysis of cyclin D2 and p27(Kip1) in cyclin D2 transgenic mouse mammary gland during development

1 reference

12 December 2020